More Garlic, Less Cancer?

In a small study published in a recent issue of the journal Analytical Biochemistry, results suggested that the more garlic people consumed, the lower the levels of the potential carcinogenic process were.
The research is all about body processes associated with nitrogen-containing compounds,scientists say. These processes include nitrosation, or the conversion of some substances found in foods or contaminated water into carcinogens.
“What we were after was developing a method where we could measure in urine two
different compounds, one related to the risk for cancer, and the other, which indicates the extent of consumption of garlic,” said Earl Harrison, Dean’s Distinguished Professor of Human Nutrition at Ohio State, an investigator in Ohio State University’s Comprehensive Cancer Center, and senior author of the study.
“Our results showed that those were inversely related to one another – meaning that the more we had the marker for garlic consumption, the less there was of the marker for the risk of cancer.”
Ultimately, the scientists hope to find that a nutritional intervention could be a way to stop the process that develops these carcinogens.
Though the differences were slight, the consumption of 5 grams of garlic per day was associated with the lowest level of the marker for potential carcinogens. A single garlic clove typically can weigh between 1 and 5 grams.
So if you like garlic and you like garlic-containing foods, go out and have as much as you want. There’s no indication it’s going to hurt you, and it may well help you.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap